CeriBell, Inc.

NASDAQ:CBLL

Medical - Devices

Healthcare
$25.63 +1.42%

+$0.25 today

Market cap
$995.34M
Beta
0.84
P/E (TTM)
-10.9
EPS (TTM)
-$1.60
52W Low $10.85High $24.33

Volume 0.41M

Average 0.29M

CBLL Net Change in Cash

Combined operating, investing, financing, and currency effects on the cash balance during the period.

CeriBell, Inc.NASDAQ: CBLL

Net Change in Cash · Q1 FY2026 · quarter ended Mar 2026

Net change in cash turns positive

Q1 FY2026 net change in cash was $4.78M, compared with -$41.01M a year earlier. Trailing-twelve-month net change in cash was -$108.11M.

Context

  • Net change in cash amounted to 172.8% of revenue in FY2025, down 71.5 pp from a year earlier.
  • Net change in cash increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly net change in cash holds near $4.78M or moves back toward the trailing-twelve-month quarterly average of -$27.03M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$4.78M-71.5% QoQ
Last fiscal yearDec 2025
-$153.89M-196.3% YoY
LTMMar 2026
-$108.11M-189.4% YoY
Net Change in Cash past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+111.6%——
1 year-196.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Net Change in Cash history

USD · from the cash flow

Latest · FY2025
(153.89M) USD
Year-over-year change
-196.3%

Net Change in Cash vs competitors

How CBLL compares with its peers on the latest reported figures

  • CBLL's LTM Mar 2026 net change in cash of $108.11M is the largest of the 7 companies compared; the peer median is $12.6M.
  • Its year-over-year change of -189.4% is the 6th highest of 7, against a peer median of -106.7%.
  • Net change in cash amounts to 113.7% of revenue for CBLL, versus a peer median of 8.9%.
CBLL Competitors Peer median
Net Change in Cash for CBLL and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CBLLCeriBell, Inc.LTM Mar 2026$108.11M -189.4%—113.7%
LIVNLivaNova PLCLTM Sep 2026$82.56M +302.8%—5.5%
CVRXCVRx, Inc.LTM Mar 2026$30.37M -234.6%-5.6%51.4%
BWAYBrainsWay Ltd.LTM Mar 2026$12.97M -121.9%—23.1%
NPCENeuroPace, Inc.LTM Mar 2026$12.24M -187.3%—12.3%
STIMNeuronetics, Inc.LTM Mar 2026$2.26M -91.5%—1.5%
ECORelectroCore, Inc.LTM Mar 2026$825K +120.3%—2.4%
Peer median (excluding CBLL) $12.6M-106.7%-5.6%8.9%

Competitors are the stored peer set for CBLL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(37.16M)(29.46M)(40.46M)(53.41M)
Depreciation & Amortization497K847K1.14M(670K)
Deferred Income Tax0000
Stock-Based Compensation7.93M2.68M5.41M12.22M
Change in Working Capital(3.88M)(3.7M)(3.17M)633K
Accounts Receivables(3.96M)(3.43M)(3.51M)(4.18M)
Inventory(1.9M)(1.79M)(1.07M)(351K)
Accounts Payables124K309K250K1.75M
Other Working Capital1.85M1.22M1.16M3.41M
Other Non-Cash Items621K477K2.03M418K
Operating Cash Flow(32M)(29.16M)(35.04M)(40.81M)
Capital Expenditures(516K)(983K)(1.34M)(767K)
Acquisitions (Net)0000
Purchases of Investments000(210.82M)
Sales of Investments00094.2M
Other Investing Activities(883K)(780K)(258K)(755K)
Investing Cash Flow(1.4M)(1.76M)(1.6M)(118.14M)
Debt Repayment(39K)(3.75M)7.91M0
Common Stock Issued00188.92M5.44M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities154K932K(304K)(386K)
Financing Cash Flow49.81M(2.82M)196.52M5.05M
Effect of Forex Changes0000
Net Change in Cash16.4M(33.74M)159.88M(153.89M)
Free Cash Flow(32.52M)(30.14M)(36.38M)(41.58M)

CeriBell, Inc.

NASDAQ:CBLL

Intrinsic Alpha fair value

Locked

Current Price

$25.63

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.